» Authors » Matthias Port

Matthias Port

Explore the profile of Matthias Port including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 121
Citations 780
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Schule S, Hackenbroch C, Beer M, Ostheim P, Hermann C, Muhtadi R, et al.
PLoS One . 2024 Dec; 19(12):e0315808. PMID: 39705301
Background: The tin (Sn) prefilter technique is a recently introduced dose-saving technique in computed tomography (CT). This study investigates whether there is an altered molecular biological response in blood cells...
2.
Strobel I, Schumann S, Muller J, Buck A, Port M, Lassmann M, et al.
Int J Mol Sci . 2024 Aug; 25(16). PMID: 39201316
The combination of high and low LET radionuclides has been tested in several patient studies to improve treatment response. Radionuclide mixtures can also be released in nuclear power plant accidents...
3.
Muhtadi R, Bernhardt D, Multhoff G, Honikl L, Combs S, Krieg S, et al.
Cancers (Basel) . 2024 Jul; 16(13). PMID: 39001407
GBM WHO CNS Grade 4 represents a major challenge for oncology due to its aggressive behavior. Conventional imaging has restrictions in detecting tumor recurrence. This prospective study aims to identify...
4.
Brzoska K, Abend M, OBrien G, Gregoire E, Port M, Badie C
Int J Radiat Biol . 2024 Jul; 100(8):1202-1212. PMID: 38953870
Purpose: Radiation-induced alterations in gene expression show great promise for dose reconstruction and for severity prediction of acute health effects. Among several genes explored as potential biomarkers, FDXR is widely...
5.
Blakely W, Port M, Ostheim P, Abend M
Radiat Res . 2024 Jun; 202(2):185-204. PMID: 38936821
A multiple-parameter based approach using radiation-induced clinical signs and symptoms, hematology changes, cytogenetic chromosomal aberrations, and molecular biomarkers changes after radiation exposure is used for biodosimetry-based dose assessment. In the...
6.
Schumann S, Scherthan H, Hartrampf P, Goring L, Buck A, Port M, et al.
Int J Mol Sci . 2024 May; 25(10). PMID: 38791531
This work reports on a model that describes patient-specific absorbed dose-dependent DNA damage response in peripheral blood mononuclear cells of thyroid cancer patients during radioiodine therapy and compares the results...
7.
Schule S, Bunert F, Hackenbroch C, Beer M, Ostheim P, Stewart S, et al.
Radiat Res . 2024 Jan; 201(5):396-405. PMID: 38282002
After nuclear scenarios, combined injuries of acute radiation syndrome (ARS) with, e.g., abdominal trauma, will occur and may require contrast-enhanced computed tomography (CT) scans for diagnostic purposes. Here, we investigated...
8.
Schwanke D, Valente M, Ostheim P, Schule S, Bobyk L, Drouet M, et al.
Int J Radiat Biol . 2024 Jan; 100(4):527-540. PMID: 38227483
Purpose: In a previous baboon-study, a total of 29 genes were identified for clinical outcome prediction of the hematologic, acute, radiation, syndrome (H-ARS) severity. Among them, four genes ( appeared...
9.
Scherthan H, Geiger B, Ridinger D, Muller J, Riccobono D, Bestvater F, et al.
Biomolecules . 2023 Oct; 13(10). PMID: 37892200
Exposure to high acute doses of ionizing radiation (IR) can induce cutaneous radiation syndrome. Weeks after such radiation insults, keratinocyte nuclei of the epidermis exhibit persisting genomic lesions that present...
10.
Meindl M, Blaske A, Steiger K, Lindner S, Lindheimer F, Lauber K, et al.
Eur J Nucl Med Mol Imaging . 2023 Oct; 51(2):395-404. PMID: 37796306
Purpose: A reliable method for regional in vivo imaging of radiation-induced cellular damage would be of great importance for the detection of therapy-induced injury to healthy tissue and the choice...